In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vascular Therapies

Division of Medtronic PLC

Latest From Vascular Therapies

Novoste: Proving the Exception

Novoste is out to show that the changing device world still has room, in the right market, for a small single-product company to succeed against larger competitors.
Medical Device Strategy

Coronary Stents: Breaking J&J's Lock on the Market

Despite increasing worldwide competition, the coronary stent market continues to be technology driven, as new devices allow interventional cardiologists to customize treatment for different kinds of lesions. In the US, J&J’s patent will be key to the evolution of the market, but overseas, competitors are making inroads, often with stents that address issues not satisfactorily addressed by J&J’s stent.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Alias(es)
  • Progressive Angioplasty Systems
  • Ownership
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Medtronic PLC
  • Senior Management
  • Robert Hess, Pres. & CEO
    Glen K Furata, VP, Fin. and Admin.
    Walter Blair, VP, Sales & Marketing
    Jerome Jackson, VP, R&D
  • Contact Info
  • Vascular Therapies
    Phone: (415) 322-5658
    1350 Willow Road, Suite 201
    Menlo Park, CA 94025